Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
9MW0813
DRUG
2 trials
Sponsors
Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions
Diabetic Macular Edema
Phase 1
Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
Completed
NCT05324592
Mabwell (Shanghai) Bioscience Co., Ltd.
Diabetic Macular Edema
Start: 2021-02-26
End: 2022-01-25
Updated: 2022-04-12
Phase 3
Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema
NCT05324774
Mabwell (Shanghai) Bioscience Co., Ltd.
Diabetic Macular Edema
Start: 2022-02-28
End: 2024-07-30
Target: 346
Updated: 2022-04-12